$JSPR
Jasper Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Redwood City, CA
JSPR chart
What traders are saying about $JSPR
Latest postsJasper Therapeutics, Inc. news
- Jasper Therapeutics, Inc. Estimates – NASDAQ:JSPR
TradingView ·
- Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
Yahoo Finance ·
- Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
Yahoo Finance ·
- Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
Yahoo Finance ·
- Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Jasper Therapeutics beats Q2 expectations but shares fall after results
investorshub.advfn.com ·
- Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
- Jasper gets a lifeline in merger with immune drugmaker Kira
biopharmadive.com ·
- Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
Yahoo Finance ·
- Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight
Yahoo Finance ·
- Bears are Losing Control Over Jasper Therapeutics (JSPR), Here's Why It's a 'Buy' Now
Yahoo Finance ·
- Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
Yahoo Finance ·
Jasper Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$75.8 | -$71.3M | -$64.5M | -$37.7M |
| Diluted EPS | $-3.95 | $-4.89 | $-6.18 | $-10.33 |
| Total assets (year end) | $35.8M | $79.9M | $94.9M | $48.4M |
| Cash and equivalents (year end) | $28.7M | $71.6M | $86.9M | $38.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Jasper Therapeutics, Inc.
- Ticker
- JSPR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Redwood City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1788028
- Former names
- Amplitude Healthcare Acquisition Corp
Frequently asked questions
What exchange is Jasper Therapeutics, Inc. listed on?
Jasper Therapeutics, Inc. trades on the Nasdaq under the ticker symbol JSPR.
What industry is Jasper Therapeutics, Inc. in?
Jasper Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Jasper Therapeutics, Inc. headquartered?
Jasper Therapeutics, Inc.'s business address on file with the SEC is in Redwood City, CA.
When does Jasper Therapeutics, Inc.'s fiscal year end?
Jasper Therapeutics, Inc.'s fiscal year ends on December 31.